75.65 USD
-0.48 (-0.63%)
Overall ESTA gets a fundamental rating of 3 out of 10. We evaluated ESTA against 185 industry peers in the Health Care Equipment & Supplies industry. While ESTA seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, ESTA is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ESTA had negative earnings in the past year.
In the past year ESTA has reported a negative cash flow from operations.
In the past 5 years ESTA always reported negative net income.
ESTA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ESTA's Return On Assets of -24.62% is in line compared to the rest of the industry. ESTA outperforms 48.65% of its industry peers.
Looking at the Return On Equity, with a value of -509.99%, ESTA is doing worse than 82.70% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.62% | ||
| ROE | -509.99% | ||
| ROIC | N/A |
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ESTA (68.74%) is better than 74.59% of its industry peers.
ESTA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ESTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.74% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
2. Health
2.1 Basic Checks
ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ESTA has more shares outstanding
ESTA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ESTA has an improved debt to assets ratio.
2.2 Solvency
ESTA has an Altman-Z score of 2.68. This is not the best score and indicates that ESTA is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.68, ESTA is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
ESTA has a Debt/Equity ratio of 15.06. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 15.06, ESTA is doing worse than 88.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 15.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.68 |
ROIC/WACCN/A
WACC8.39%
2.3 Liquidity
ESTA has a Current Ratio of 3.33. This indicates that ESTA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.33, ESTA is in line with its industry, outperforming 58.92% of the companies in the same industry.
A Quick Ratio of 2.10 indicates that ESTA has no problem at all paying its short term obligations.
The Quick ratio of ESTA (2.10) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.33 | ||
| Quick Ratio | 2.1 |
3. Growth
3.1 Past
The earnings per share for ESTA have decreased strongly by -10.08% in the last year.
ESTA shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.76%.
The Revenue has been growing by 13.13% on average over the past years. This is quite good.
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
Revenue 1Y (TTM)24.76%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%
3.2 Future
The Earnings Per Share is expected to grow by 25.95% on average over the next years. This is a very strong growth
Based on estimates for the next years, ESTA will show a very strong growth in Revenue. The Revenue will grow by 26.34% on average per year.
EPS Next Y36.22%
EPS Next 2Y28.48%
EPS Next 3Y26.61%
EPS Next 5Y25.95%
Revenue Next Year26.58%
Revenue Next 2Y25.76%
Revenue Next 3Y25.9%
Revenue Next 5Y26.34%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ESTA. In the last year negative earnings were reported.
Also next year ESTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ESTA's earnings are expected to grow with 26.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.48%
EPS Next 3Y26.61%
5. Dividend
5.1 Amount
No dividends for ESTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:ESTA (12/24/2025, 8:27:17 PM)
75.65
-0.48 (-0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners105.25%
Inst Owner Change-2%
Ins Owners13.63%
Ins Owner Change0.56%
Market Cap2.20B
Revenue(TTM)190.97M
Net Income(TTM)-83.45M
Analysts84
Price TargetN/A
Short Float %18.67%
Short Ratio8.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.36%
Min EPS beat(2)-4.97%
Max EPS beat(2)29.69%
EPS beat(4)2
Avg EPS beat(4)-8.99%
Min EPS beat(4)-75.04%
Max EPS beat(4)29.69%
EPS beat(8)5
Avg EPS beat(8)-2.35%
EPS beat(12)8
Avg EPS beat(12)0.53%
EPS beat(16)9
Avg EPS beat(16)-21.43%
Revenue beat(2)1
Avg Revenue beat(2)-0.05%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)1.38%
Revenue beat(4)1
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)1.38%
Revenue beat(8)3
Avg Revenue beat(8)-0.76%
Revenue beat(12)5
Avg Revenue beat(12)-1.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)29.93%
PT rev (3m)30.79%
EPS NQ rev (1m)-2.1%
EPS NQ rev (3m)22.8%
EPS NY rev (1m)10.79%
EPS NY rev (3m)10.55%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)0.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 11.51 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 134.35 | ||
| P/tB | 462.33 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.84
EYN/A
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)-2.47
OCFYN/A
SpS6.57
BVpS0.56
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.62% | ||
| ROE | -509.99% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.74% | ||
| FCFM | N/A |
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 15.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 76.51% | ||
| Cap/Sales | 3.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.33 | ||
| Quick Ratio | 2.1 | ||
| Altman-Z | 2.68 |
F-Score4
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)567.48%
Cap/Depr(5y)397.75%
Cap/Sales(3y)15.14%
Cap/Sales(5y)11.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.59%
EPS Next Y36.22%
EPS Next 2Y28.48%
EPS Next 3Y26.61%
EPS Next 5Y25.95%
Revenue 1Y (TTM)24.76%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%33.7%
Revenue Next Year26.58%
Revenue Next 2Y25.76%
Revenue Next 3Y25.9%
Revenue Next 5Y26.34%
EBIT growth 1Y-1.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.34%
EBIT Next 3Y44.7%
EBIT Next 5Y43.82%
FCF growth 1Y36.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.01%
OCF growth 3YN/A
OCF growth 5YN/A
ESTABLISHMENT LABS HOLDINGS / ESTA FAQ
What is the fundamental rating for ESTA stock?
ChartMill assigns a fundamental rating of 3 / 10 to ESTA.
Can you provide the valuation status for ESTABLISHMENT LABS HOLDINGS?
ChartMill assigns a valuation rating of 1 / 10 to ESTABLISHMENT LABS HOLDINGS (ESTA). This can be considered as Overvalued.
Can you provide the profitability details for ESTABLISHMENT LABS HOLDINGS?
ESTABLISHMENT LABS HOLDINGS (ESTA) has a profitability rating of 1 / 10.
Can you provide the financial health for ESTA stock?
The financial health rating of ESTABLISHMENT LABS HOLDINGS (ESTA) is 4 / 10.